IP Library › Granted Patent US 7,968,113
Granted Patent B2
US 7,968,113 · App. 12/011,879 · Granted Jun 28, 2011

Liquid bandages

Assignee: Biomedical Development Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,113
App. No.
12/011,879
Granted
Jun 28, 2011
Kind
B2
Abstract

A method is provided to treat skin to restore barrier homeostasis and to promote normal stratum corneum function by applying to the skin a liquid composition which forms a phase inversion membrane. The amount of solids in the liquid composition is varied so as to provide a desired degree of porosity to the resulting membrane.

Claims (15)

1. A method for treating skin of a patient to restore barrier homeostasis and to promote normal stratum corneum function without medicaments which comprises applying to the skin a liquid composition that forms a phase inversion membrane having a moisture vapor transmission rate of greater than 20 g/m 2 /24 hr which composition comprises

a) about 5 to 35% by weight of solids of a neutralized acrylic resin and polyvinylidene difluoride or the copolymers thereof in a ratio of 1:4 to 1:2;

b) about 1 to 11% by weight of water; and

c) acetone;

with the proviso that the acrylic resin is in the form of an aqueous emulsion and the emulsion is formed by varying the amount of solids to arrive at a degree of desired porosity in the resultant membrane.

2. The method of claim 1 wherein the membrane forms an occlusive or semi-occlusive bandage.

3. The method of claim 1 wherein the skin is treated for wrinkles.

4. The method of claim 1 wherein the skin is treated for scars.

5. The method of claim 1 wherein a phase inversion membrane of about 40 μm in thickness is formed.

6. The method of claim 1 wherein the phase inversion membrane forming composition comprises

a) about 6 to 18% by weight of a polymer selected from the group consisting of polyvinylidene difluoride and the copolymers thereof;

b) about 1 to 6% by weight of an emulsion of a neutralized acrylic resin selected from the group consisting of acrylic acid, methacrylic acid, alkyl acrylate and alkyl methacrylate;

c) about 1 to 6% by weight of water; and

d) acetone.

7. The method of claim 1 wherein the patient is suffering from keratosis pilaris.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2011
From: SIEGEL, GREGG; SIEGEL, PHYLLIS
To: BIOMEDICAL DEVELOPMENT CORPORATION
Reel/Frame 026374/0492 →
Continuity (1)
Related Publication 20090192475A1 · Jul 30, 2009